- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 7/56 - Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
Patent holdings for IPC class C07K 7/56
Total number of patents in this class: 580
10-year publication summary
|
39
|
45
|
40
|
37
|
43
|
26
|
33
|
46
|
45
|
29
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4742 |
50 |
| Shanghai Techwell Biopharmaceutical Co., Ltd. | 65 |
38 |
| Protagonist Therapeutics, Inc. | 154 |
13 |
| Palatin Technologies, Inc. | 61 |
12 |
| Aileron Therapeutics, Inc. | 78 |
10 |
| Zealand Pharma A/S | 270 |
10 |
| Endevica bio, Inc. | 63 |
9 |
| DSM Sinochem Pharmaceuticals Netherlands B.V. | 60 |
8 |
| NovoBiotic Pharmaceuticals, LLC | 23 |
8 |
| Provincial Health Services Authority | 195 |
8 |
| Bicyclerd Limited | 155 |
8 |
| Polyphor Ltd. | 12 |
7 |
| The University of Tokyo | 4361 |
7 |
| Xellia Pharmaceuticals ApS | 93 |
7 |
| Novartis AG | 10262 |
6 |
| President and Fellows of Harvard College | 6094 |
6 |
| The University of British Columbia | 1538 |
6 |
| Shanghai Shengdi Pharmaceutical Co., Ltd | 164 |
6 |
| Shanghai Senhui Medicine Co., Ltd. | 91 |
6 |
| Farsight Medical Technology (Shanghai) Co., Ltd. | 26 |
6 |
| Other owners | 349 |